Rheumatoid arthritis and lupus belong to a number of autoimmune diseases affecting the musculoskeletal system, multisystemic tissue, and connective tissues. Although a range of autoimmune conditions carry a low prevalence, combined these diseases amount to a growing medical and economic burden. Additionally, autoimmune diseases are accounting for a growing cause of disability in the United States, Europe and worldwide.
Kalorama’s Worldwide Market for Rheumatoid Arthritis and Lupus Treatments (Autoimmune Disease Markets) is the most comprehensive look at the markets for treatments for these two important diseases in the autoimmune disorder category: rheumatoid arthritis and lupus. As part of its thorough, ground up research– the product of interviews with market experts conducted by an experienced pharmaceutical market analyst, this report includes:
- Market Size and Forecast for NSAIDs and Biologic Treatments
- New Products in Development
- Important Issues and Trends
- Company Profiles
- Market Share
- Regional Revenues Breakout
Product Managers, marketing managers, business development executives and investment professionals are among those who will find this report to be a useful resource.